VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
暂无分享,去创建一个
C. Weiss | M. Wehling | H. Burkhardt | H. Frohnhofen | F. Pazan | Alexandra Kuhn-Thiel | C. Throm | Christina Throm
[1] M. Wehling. How to Use the FORTA (“Fit fOR The Aged”) List to Improve Pharmacotherapy in the Elderly , 2015, Drug Research.
[2] G. Onder,et al. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. , 2014, Age and ageing.
[3] Paul Gallagher,et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.
[4] M. Wehling,et al. Effects of “Fit fOR The Aged” (FORTA) on pharmacotherapy and clinical endpoints—a pilot randomized controlled study , 2014, European Journal of Clinical Pharmacology.
[5] C. Weiss,et al. Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly , 2013, Drugs & Aging.
[6] Paul J Nietert,et al. The Prevalence of Chronic Diseases and Multimorbidity in Primary Care Practice: A PPRNet Report , 2013, The Journal of the American Board of Family Medicine.
[7] C. Campanelli. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .
[8] H. Frohnhofen,et al. Bewertung von Medikamenten in der Geriatrie mit der neuen FORTA-Klassifikation , 2011, Deutsche medizinische Wochenschrift.
[9] P. Gallagher,et al. Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria , 2011, Clinical pharmacology and therapeutics.
[10] Martin Wehling,et al. GUIDELINE‐DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS , 2011, Journal of the American Geriatrics Society.
[11] Sven Schmiedl,et al. Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.
[12] D. Light. 1. Bearing the Risks of Prescription Drugs , 2010 .
[13] M. Wehling. MULTIMORBIDITY AND POLYPHARMACY: HOW TO REDUCE THE HARMFUL DRUG LOAD AND YET ADD NEEDED DRUGS IN THE ELDERLY? PROPOSAL OF A NEW DRUG CLASSIFICATION: FIT FOR THE AGED , 2009, Journal of the American Geriatrics Society.
[14] M. Wehling,et al. [Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA]. , 2008, Deutsche medizinische Wochenschrift.
[15] P. Gallagher,et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.
[16] R. Page,et al. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. , 2006, The American journal of geriatric pharmacotherapy.
[17] D. Pollock,et al. National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.
[18] Claudio Pedone,et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. , 2005, Archives of internal medicine.
[19] J. Gurwitz. Polypharmacy: a new paradigm for quality drug therapy in the elderly? , 2004, Archives of internal medicine.
[20] R. Bressler,et al. Principles of drug therapy for the elderly patient. , 2003, Mayo Clinic proceedings.
[21] Stephen H. D. Jackson,et al. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. , 2003, British journal of clinical pharmacology.
[22] A. Mitchell,et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.
[23] J A Knottnerus,et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. , 1998, Journal of clinical epidemiology.